Effectiveness of empiric carbapenem versus non-carbapenem therapy for extended-spectrum β-lactamase producing Enterobacterales infections in non-intensive care unit patients: a real-world investigation in a hospital with high-prevalence of extended-spectrum β-lactamase producing Enterobacterales

By sjmartinez • June 5, 2024

Kang AY, Elkomos M, Pham D, Guerrero M, Kupferwasser D, Miller LG. Effectiveness of empiric carbapenem versus non-carbapenem therapy for extended-spectrum β-lactamase producing Enterobacterales infections in non-intensive care unit patients: a real-world investigation in a hospital with high-prevalence of extended-spectrum β-lactamase producing Enterobacterales. Antimicrob Steward Healthc Epidemiol. 2024 Jun 4;4(1):e100. doi: 10.1017/ash.2024.88. PMID: 38836043; PMCID: PMC11149041.

Tags: Harbor UCLA, Infectious Diseases, Publications

Quality measures in the delivery of equitable endoscopic care to traditionally underserved patients in the United States

ASGE Quality Assurance in Endoscopy Committee; Williams KN, May FP, Cummings LC, Srivastava N, Shahidi N, Kohansal A, Panganamamula K, Garg R, Singh A, Green[...]

Calcified aneurysm in the left anterior descending artery

Bishay R, Krishnan S, Budoff MJ. Calcified aneurysm in the left anterior descending artery. Coron Artery Dis. 2024 Oct 15. doi: 10.1097/MCA.0000000000001436. Epub ahead of[...]

Viral and symptom rebound following anti-SARS-CoV-2 monoclonal antibody therapy in a randomized placebo-controlled trial

Chew KW, McGinley B, Moser C, Li JZ, Evering TH, Ritz J, Javan AC, Margolis D, Wohl DA, Hughes MD, Daar ES, Currier JS, Eron[...]